CoreAge Rx vs Nolu
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Readers comparing prepaid, dose-independent compounded-injection plans who can confirm their state eligibility and the complete payment terms.
- semaglutide
- From $79/mo12-month prepay
- tirzepatide
- From $129/mo12-month prepay
Before enrolling
The advertised starting $79/$129 monthly equivalents require a 12-month plan paid in full; no month-to-month price was established
Desk Score
Patients who want one bundled per-order price and will budget for 13 billing cycles a year rather than 12.
- semaglutide
- $249/mosee billing conditions
- tirzepatide
- $339/mosee billing conditions
Before enrolling
Billed "per 4 weeks," not per calendar month — the real annualized cost runs roughly 8% above the $249/$339 headline
Our review of CoreAge Rx gives it 94/100 (A), while our review of Nolu gives it 78/100 (C+). The score breakdown shows where each provider does better.
Desk Score, dimension by dimension
Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.
94/100
A
78/100
C+
The spec sheet
Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.
| Field | CoreAge Rx | Nolu |
|---|---|---|
| Semaglutide | From $79/mo12-month prepayFull plan termsFrom $79/mo (12-month plan paid in full; confirm the complete charge before paying; no month-to-month price established; same price at every dose according to the FAQ; compounded injectable) | $249/mosee billing conditionsFull plan terms$249/mo injectable · $279/mo oral (billed per 4 weeks) |
| Tirzepatide | From $129/mo12-month prepayFull plan termsFrom $129/mo (12-month plan paid in full; confirm the complete charge before paying; no month-to-month price established; same price at every dose according to the FAQ; compounded injectable) | $339/mosee billing conditionsFull plan terms$339/mo injectable (billed per 4 weeks) |
| Coverage | U.S. service; treatment-specific state eligibility confirmed during intake | All 50 states + DC |
| Brand-name | Not confirmed here | Not confirmed here |
| Oral option | Not confirmed here | Oral option listed |
| Best for | Readers comparing prepaid, dose-independent compounded-injection plans who can confirm their state eligibility and the complete payment terms. | Patients who want one bundled per-order price and will budget for 13 billing cycles a year rather than 12. |
| Desk Score | 94/100A | 78/100C+ |
The verdict
Desk pick — CoreAge RxCoreAge Rx has the higher Desk Score, but Nolu may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.
Readers comparing prepaid, dose-independent compounded-injection plans who can confirm their state eligibility and the complete payment terms.
Patients who want one bundled per-order price and will budget for 13 billing cycles a year rather than 12.
More head-to-heads
- CoreAge Rx vs Strut Health
- MadeMed vs Nolu
- CoreAge Rx vs Ondra Health
- Clume Health vs Nolu
- CoreAge Rx vs Sesame Care
- Goldspan Health vs Nolu
Or see the full comparison hub and the complete ranking.